EKF Diagnostics Holdings (FRA:LYF) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:LYF EKF Diagnostics Holdings PLC FRA:LYF
52 GF Score
Price €0.29
GF Value €0.32
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is EKF Diagnostics Holdings Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

FRA:LYF
52GF Score
EKF Diagnostics Holdings PLC FRA:LYF
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is EKF Diagnostics Holdings (FRA:LYF) Overvalued in 2026?

Based on GuruFocus' analysis, EKF Diagnostics Holdings stock appears to be undervalued. The current stock price of €0.29 is trading 10.6% below its estimated GF Value™ of €0.32. GuruFocus considers EKF Diagnostics Holdings to be Modestly Undervalued.

Key valuation signals for FRA:LYF:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: €0.32 vs. price of €0.29 (10.6% below fair value)
  • GF Score™: 52/100 with 4 warning signs

No single metric tells the full story. See the FRA:LYF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

EKF Diagnostics Holdings Business Description

Other Exchanges EKDHF:USAEKF:UK
Address 19 Stanwell Road, Avon House, Penarth, Cardiff, GBR, CF64 2EZ
EKF Diagnostics Holdings PLC is engaged in development, manufacture and supply of products and services into the in-vitro diagnostic (IVD) market place. The Group has presence in the UK, USA, Germany, and Russia, and sells throughout the world including Europe, the Middle East, the Americas, Asia, and Africa. It derive their revenue from the manufacture and sale of medical diagnostic equipment and reagents. Other services include the servicing and distribution of third party company products under separate distribution agreements.
52GF Score

Get the complete analysis for FRA:LYF

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.29
Price
€0.32
GF Value